Literature DB >> 5698437

Indomethacin, reduced retinal sensitivity, and corneal deposits.

C A Burns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5698437     DOI: 10.1016/0002-9394(68)92796-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  9 in total

1.  Non-steroid anti-inflammatory agents.

Authors: 
Journal:  Br Med J       Date:  1970-08-22

Review 2.  Differences in NSAID tolerability profiles. Fact or fiction?

Authors:  K J Skeith; M Wright; P Davis
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

3.  X-chromosomal-linked diseases affecting the eye: status of the heterozygote female.

Authors:  A E Krill
Journal:  Trans Am Ophthalmol Soc       Date:  1969

Review 4.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

Review 5.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

Review 6.  Indomethacin retinopathy: case report and review.

Authors:  C M Graham; R K Blach
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

Review 7.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

8.  Paediatric Fabry disease: prognostic significance of ocular changes for disease severity.

Authors:  Gisela Kalkum; Susanne Pitz; Nesrin Karabul; Michael Beck; Guillem Pintos-Morell; Rossella Parini; Marianne Rohrbach; Svetlana Bizjajeva; Uma Ramaswami
Journal:  BMC Ophthalmol       Date:  2016-11-16       Impact factor: 2.209

Review 9.  Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.

Authors:  Rosanna Dammacco; Silvana Guerriero; Giovanni Alessio; Franco Dammacco
Journal:  Int Ophthalmol       Date:  2021-11-21       Impact factor: 2.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.